Jacqueline O Leary
Gastroenterology · Dallas, TXNPI 1336121565
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $97,535 of the $156,730 with a category attached, or 62.2%. 11 manufacturers reported payments, led by AbbVie at 48.2% of the total. Reporting peaked in 2019 at $87,430 and has fallen 97.8% since, to $1,922 in 2025. Among gastroenterology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 186 payments — averaging $842.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$76K
- Gilead$60K
- Mallinckrodt Hospital Products Inc.$13K
- Grifols Therapeutics LLC$3K
- Novo Nordisk AS$2K
- Intercept Pharmaceuticals, Inc.$1K
- plus $1K from 5 others
Across 329 payments — averaging $3727.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Grifols Therapeutics LLC$587K
- Bausch Health US, LLC$404K
- Madrigal Pharmaceuticals$144K
- Grifols Biologicals LLC$54K
- Mallinckrodt Enterprises LLC$19K
- AbbVie$16K
- plus $2K from 1 others
What the payments were for
- Consulting fees$38,62825%
- Speaking & faculty fees$97,53562%
- Travel & lodging$16,60711%
- Food & beverage$3,9613%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 108 | $75,592 |
| Gilead | 63 | $60,103 |
| Mallinckrodt Hospital Products Inc. | 6 | $13,362 |
| Grifols Therapeutics LLC | 1 | $3,250 |
| Novo Nordisk AS | 1 | $2,325 |
| Intercept Pharmaceuticals, Inc. | 2 | $1,000 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $750 |
| Grifols, S.A. | 1 | $118 |
| Novo Nordisk | 1 | $94 |
| Mallinckrodt Enterprises LLC | 1 | $73 |
| Madrigal Pharmaceuticals | 1 | $62 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$156,730 in reported general payments places this provider in the 95th percentile of 1,350 gastroenterology providers in Texas.
Other gastroenterology in Dallas
- John FordtranDallas$9.9M
- Michael BrownDallas$5.5M
- Parvez MantryDallas$958K
- Jay HortonDallas$326K
- Sami ArslanlarDallas$142K
- Amit DesaiDallas$71K
- Byron CryerDallas$68K
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.